PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CD4 112,219 Target Drug Dronabinol 203 5 0.00 -0.99 0.02 0.57
CD4 112,219 Target Disease Mycetoma 1,240 5 0.00 -1.00 0.00 0.53
CD4 112,219 Target Target Cytokeratin 20 847 2 0.00 -1.00 0.00 0.52
CD4 112,219 Target Disease Amnesia 8,173 2 0.00 -1.00 0.00 0.46
CD4 112,219 Target Target Complement Decay-Accelerating Factor 19 1 0.00 -0.97 0.05 0.57
CD4 112,219 Target Disease Poisoning 53,779 30 0.00 -1.00 0.00 0.48
CD4 112,219 Target Disease Nervousness 1,244 4 0.00 -1.00 0.00 0.52
CD4 112,219 Target Disease Chronic Pain 21,087 9 0.00 -1.00 0.00 0.47
CD4 112,219 Target Disease Chills 3,046 45 0.00 -0.99 0.01 0.57
CD4 112,219 Target Disease Sedimentation Rate 11,455 141 0.00 -0.99 0.01 0.58
CD4 112,219 Target Disease Muscle Cramps 855 2 0.00 -1.00 0.00 0.52
CD4 112,219 Target Disease Shigella Infection 244 6 0.00 -0.99 0.02 0.57
CD4 112,219 Target Disease Burns 26,206 37 0.00 -1.00 0.00 0.51
CD4 112,219 Target Disease Obesity 138,233 197 0.00 -1.00 0.00 0.51
CD4 112,219 Target Target Ns3 3,189 139 0.01 -0.98 0.04 0.61
CD4 112,219 Target Disease Social Anxiety 3,287 1 0.00 -1.00 0.00 0.47
CD4 112,219 Target Target AMAC-1 19 1 0.00 -0.97 0.05 0.57
CD4 112,219 Target Disease Deep Vein Thrombosis 10,952 7 0.00 -1.00 0.00 0.49
CD4 112,219 Target Disease Ear Infections 765 2 0.00 -1.00 0.00 0.52
CD4 112,219 Target Disease Drug Abuse 13,496 137 0.00 -0.99 0.01 0.57
CD4 112,219 Target Disease Hearing Loss 30,622 37 0.00 -1.00 0.00 0.50
CD4 112,219 Target Disease Carcinoma 433,099 1,988 0.01 -0.99 0.02 0.56
CD4 112,219 Target Disease Mental Illnesses 2,361 2 0.00 -1.00 0.00 0.49
CD4 112,219 Target Disease Myasthenia Gravis 11,268 286 0.01 -0.99 0.03 0.60
CD4 112,219 Target Disease Overactive Bladder 3,492 2 0.00 -1.00 0.00 0.48
CD4 112,219 Target Disease Cervical Cancer 28,286 299 0.01 -0.99 0.01 0.58
CD4 112,219 Target Drug Abilify (Aripiprazole)- FDA 71 1 0.00 -0.99 0.01 0.55
CD4 112,219 Target Disease Varicose Veins 5,072 1 0.00 -1.00 0.00 0.46
CD4 112,219 Target Disease Candidemia 1,512 10 0.00 -1.00 0.01 0.54
CD4 112,219 Target Drug Abacavir Sulfate 41 3 0.00 -0.96 0.07 0.58
CD4 112,219 Target Disease Endometriosis 16,342 45 0.00 -1.00 0.00 0.53
CD4 112,219 Target Disease Metastatic Breast Cancer 9,288 42 0.00 -1.00 0.00 0.54
CD4 112,219 Target Target ASK1 762 1 0.00 -1.00 0.00 0.50
CD4 112,219 Target Disease Eczema 12,327 123 0.00 -0.99 0.01 0.57
CD4 112,219 Target Disease Hemorrhage 100,979 96 0.00 -1.00 0.00 0.49
CD4 112,219 Target Disease Depression 220,092 775 0.00 -0.99 0.01 0.55
CD4 112,219 Target Target CEA 17,022 116 0.00 -1.00 0.01 0.56
CD4 112,219 Target Disease Osteoarthritis 36,287 128 0.00 -1.00 0.00 0.54
CD4 112,219 Target Target Mu Opioid Receptor 4,576 13 0.00 -1.00 0.00 0.52
CD4 112,219 Target Drug Acyclovir for Injection (Zovirax Injection)- FDA 3 1 0.00 -0.82 0.33 0.60
CD4 112,219 Target Target CCNB1 160 2 0.00 -0.99 0.01 0.55
CD4 112,219 Target Target BAFF 1,240 68 0.01 -0.97 0.05 0.60
CD4 112,219 Target Target Beta-Glucosidase 4,297 2 0.00 -1.00 0.00 0.48
CD4 112,219 Target Disease Cancer 1,053,491 5,766 0.02 -0.97 0.05 0.57
CD4 112,219 Target Target BAFFR 44 2 0.00 -0.98 0.05 0.57
CD4 112,219 Target Drug Doxazosin 1,316 1 0.00 -1.00 0.00 0.49
CD4 112,219 Target Target Angiotensin Converting Enzyme 31,674 88 0.00 -1.00 0.00 0.53
CD4 112,219 Target Target C5a 4,164 51 0.00 -0.99 0.01 0.57
CD4 112,219 Target Target CCL18 256 17 0.00 -0.97 0.07 0.59
CD4 112,219 Target Disease Hives 658 3 0.00 -1.00 0.00 0.53